Fresenius confirms it’s weighing a bid for generic drugmaker Akorn https://t.co/ukTMzQ6H7p via @FT
— The Propell Group (@ThePropellGroup) April 8, 2017
#healthtech
Fresenius confirms it’s weighing a bid for generic drugmaker Akorn https://t.co/ukTMzQ6H7p via @FT
— The Propell Group (@ThePropellGroup) April 8, 2017
#healthtech